-
2021-06-10
Verona Pharma and Nuance Pharma Announce $219 Million Strategic Collaboration to Develop and Commercialize Ensifentrine in Greater China
Verona Pharma plc (Nasdaq: VRNA) and Nuance Pharma Limited today announce that the companies have entered into an agreement granting Nuance Pharma, a Shanghai
-
2020-12-08
Nuance Pharma Closes Series D Financing
Nuance Pharma announced that it has successfully closed its Series D financing which amounted to US$181 million of funding.
Contact PR
